Practical Guide to Clinical Trial Accessibility: Making Trial Participation a Standard of Care

Area of Science:

• Oncology
• Clinical Trial Design
• Health Equity

Background:

• Clinical trials are crucial for advancing cancer treatment but face significant accessibility issues.
• Structural, socioeconomic, and systemic barriers limit patient participation in clinical trials.
• Multidisciplinary stakeholders identify key challenges and propose solutions for improving trial access.

Purpose of the Study:

• To provide a collaborative overview of challenges and solutions for enhancing clinical trial accessibility.
• To synthesize perspectives from patient advocacy, community oncology, industry, and academic medicine.
• To advocate for modernizing clinical trial design and reducing access barriers.

Main Methods:

• Multidisciplinary perspective piece synthesizing stakeholder viewpoints.
• Analysis of challenges including language barriers, financial toxicity, underrepresentation, infrastructure limits, and trial complexity.
• Proposal of practical solutions such as community engagement, eligibility reform, decentralized trials, and inclusive design strategies.

Main Results:

• Patient advocates emphasize community engagement and patient-centered design to address underrepresentation and financial toxicity.
• Community oncologists call for eligibility reform and cooperative models to overcome infrastructure and practice burdens.
• Industry and academic oncologists propose strategies for inclusive design, protocol simplification, and pragmatic trial approaches.

Conclusions:

• Improving clinical trial accessibility requires a shared responsibility across all sectors involved in cancer care.
• Modernizing trial design and reducing barriers are essential for equitable participation.
• Clinical trial participation should become a standard and accessible component of cancer care for all patients.